Suchergebnisse - "Gadelha, Mônica"

PubPharm (5)

1

Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly : 14 Years of Single-Center Real-World Experience

enthalten in: The Journal of clinical endocrinology and metabolism | 2023

von Gadelha, M. | Marques, N. | Fialho, C. | +6

2

Pasireotide for acromegaly : long-term outcomes from an extension to the Phase III PAOLA study

enthalten in: European journal of endocrinology | 2020

von Colao, A. | Bronstein, M. | Brue, T. | +9

3

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

enthalten in: Endocrine | 2016

von Schmid, H. | Brue, T. | Colao, A. | +5

CommentIn: Endocrine. 2016 Oct;54(1):1-2. - PMID 27388591

4

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control : crossover extension to a randomized, double-blind, Phase III study

enthalten in: BMC endocrine disorders | 2016

von Bronstein, M. | Fleseriu, M. | Neggers, S. | +11

5

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA) : a randomised, phase 3 trial

enthalten in: The lancet. Diabetes & endocrinology | 2014

von Gadelha, M. | Bronstein, M. | Brue, T. | +63

CommentIn: Lancet Diabetes Endocrinol. 2014 Nov;2(11):855-6. - PMID 25260837

1
[1]